The CURE Innovator Award supports the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to epilepsy.
This program awards seed grants to researchers submitting innovative proposals that will provide new directions for epilepsy therapy, prevention and, ultimately, a cure. We specifically encourage studies that may not be currently fundable by other agencies, such as the National Institutes of Health, because of their preliminary or unconventional nature.
The Innovator Award is not intended to support a logical progression of an already established research project but, instead, allows Principal Investigators (PIs) the opportunity to pursue innovative research ideas.
This award mechanism supports high-risk studies that have the potential to reveal entirely new avenues for investigation. Research completed through an Innovator Award strives to provide sufficient preliminary data to enable the PI to test a groundbreaking, original, and/or unconventional hypothesis and has the potential, if successful, to open new areas for epilepsy research.
Deadline for Receipt of LOI: July 15, 2014
Deadline for Receipt of Full Application: September 25, 2014
Award Announcement: December 2014
Earliest Project Start Date: January 1, 2015
Deadline for Receipt of LOI IISPV: July 13, 2014 (europa@iispv.cat) . Deadline for Receipt of Full Application: September 12, 2014. Award Announcement: December 2014. Earliest Project Start Date: January 1, 2015
Work
C/ Dr. Mallafrè Guasch, 4
Edifici modular Hospital Universitari de Tarragona Joan XXIII
43007 Tarragona
Tel./Fax Work977 24 97 72 http://www.iispv.cathttp://www.iispv.cat
Work
C/ Sant Llorenç, 21
Planta baixa de l'edifici 4 de la Facultat de Medicina i Ciències de la Salut
43201 Reus (Tarragona)
Tel./Fax Work977 75 93 96 / 977 75 93 95
Fax977 75 93 93
http://www.iispv.cathttp://www.iispv.cat